ANANDAMIDE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A fatty amide obtained by the formal condensation of arachidonic acid with ethanolamine. (Chemical Entities of Biological Interest Ontology, CHEBI_2700)
External Link https://dgidb.org/results?searchType=drug&searchTerms=ANANDAMIDE
Similar Terms
Downloads & Tools

Genes

16 interacting proteins for the ANANDAMIDE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
KCNA2 potassium channel, voltage gated shaker related subfamily A, member 2 0.30075
GPR18 G protein-coupled receptor 18 0.30075
KCNK9 potassium channel, two pore domain subfamily K, member 9 0.30075
KCNK3 potassium channel, two pore domain subfamily K, member 3 0.254481
FAAH fatty acid amide hydrolase 0.174118
TRPM8 transient receptor potential cation channel, subfamily M, member 8 0.174118
CACNA1I calcium channel, voltage-dependent, T type, alpha 1I subunit 0.114078
GLRA1 glycine receptor, alpha 1 0.110275
CACNA1G calcium channel, voltage-dependent, T type, alpha 1G subunit 0.103383
CACNA1H calcium channel, voltage-dependent, T type, alpha 1H subunit 0.0719185
GPR55 G protein-coupled receptor 55 0.0703883
CNR2 cannabinoid receptor 2 (macrophage) 0.06015
CNR1 cannabinoid receptor 1 (brain) 0.0508961
TRPV1 transient receptor potential cation channel, subfamily V, member 1 0.0486507
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 0.00852642
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor 0.0067792